Bain Capital and Sundrug agree to transfer a portion of their equity interest in Kirindo Holdings Co.

Bain Capital Private Equity, LP (including its group, "Bain Capital") announced today that it has entered into a definitive agreement with Sundrug to transfer 33.4% of its indirect interest in Kirindo Holdings Co., and the Company has entered into a definitive agreement.

Bain Capital acquired a stake in Kirindo HD in 2020 and has been working on measures to create better stores and provide better services, including organizational reforms to increase productivity and operational improvements under a radical structural reform.

Going forward, with the participation of Sundlag as a new partner, both Kirindo HD and Sundrug will collaborate on various business initiatives to achieve further growth and a future re-listing.

Bain Capital (http://www.baincapital.com) has partnered with management teams to provide strategic resources that build great companies and help them thrive since its founding in 1984. Bain Capital Private Equity’s global team of more than 280 investment professionals creates values for its portfolio companies through its global platform and depth of expertise in key vertical industries such as healthcare, consumer/retail, financial and business services, industrials, technology, media, and telecommunications. Bain Capital has 23 offices on 4 continents. The firm has made primary or add-on investments in more than 1,150 companies since its inception. In addition to private equity, Bain Capital invests across multiple asset classes, including credit, public equity, venture capital and real estate, managing approximately $165 billion in total assets and leveraging the firm’s shared platform to capture opportunities in strategic areas of focus.